These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 9354410)

  • 1. General principles of antiarrhythmic therapy for ventricular tachyarrhythmias.
    Landers MD; Reiter MJ
    Am J Cardiol; 1997 Oct; 80(8A):31G-44G. PubMed ID: 9354410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.
    Buxton AE; Lee KL; Fisher JD; Josephson ME; Prystowsky EN; Hafley G
    N Engl J Med; 1999 Dec; 341(25):1882-90. PubMed ID: 10601507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A decade of clinical trial developments in postmyocardial infarction, congestive heart failure, and sustained ventricular tachyarrhythmia patients: from CAST to AVID and beyond. Cardiac Arrhythmic Suppression Trial. Antiarrhythmic Versus Implantable Defibrillators.
    Naccarelli GV; Wolbrette DL; Dell'Orfano JT; Patel HM; Luck JC
    J Cardiovasc Electrophysiol; 1998 Aug; 9(8):864-91. PubMed ID: 9727666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can antiarrhythmic drugs survive survival trials?
    Pratt CM; Waldo AL; Camm AJ
    Am J Cardiol; 1998 Mar; 81(6A):24D-34D. PubMed ID: 9537220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs or implantable cardioverter-defibrillators in patients with poor left ventricular function?
    Block M; Hammel D; Böcker D; Borggrefe M; Breithardt G
    Am J Cardiol; 1996 Sep; 78(5A):62-8. PubMed ID: 8820838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A; Husser D; Cannom DS
    Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical therapy to prevent recurrence of ventricular arrhythmia in normal and structural heart disease patients.
    Jacobson JT; Iwai S; Aronow W
    Expert Rev Cardiovasc Ther; 2016 Nov; 14(11):1251-1262. PubMed ID: 27494263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
    Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination antiarrhythmic drug therapy for ventricular tachyarrhythmias.
    Greenspan AM; Spielman SR; Horowitz LN
    Pacing Clin Electrophysiol; 1986 Jul; 9(4):565-76. PubMed ID: 2426675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assessment of ventricular arrhythmias].
    Osswald S; Rickenbacher P; Buser PT; Pfisterer M
    Praxis (Bern 1994); 1996 Feb; 85(7):179-87. PubMed ID: 8701182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Antiarrhythmic Medications in Medicare Part D Patients With an Implantable Cardioverter-Defibrillator and Ventricular Tachycardia.
    Pokorney SD; Mi X; Hammill BG; Allen LaPointe NM; Curtis LH; Al-Khatib SM
    Am J Cardiol; 2017 May; 119(9):1401-1406. PubMed ID: 28341360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of arrhythmias in heart failure.
    O'Callaghan PA; Camm AJ
    Eur J Heart Fail; 1999 Jun; 1(2):133-7. PubMed ID: 10937922
    [No Abstract]   [Full Text] [Related]  

  • 14. Importance of beta blockade in the therapy of serious ventricular arrhythmias.
    Reiter MJ; Reiffel JA
    Am J Cardiol; 1998 Aug; 82(4A):9I-19I. PubMed ID: 9737650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic and nonantiarrhythmic drugs for sudden cardiac death prevention.
    Das MK; Zipes DP
    J Cardiovasc Pharmacol; 2010 May; 55(5):438-49. PubMed ID: 20509177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy in inherited and acquired ventricular arrhythmia in structurally normal adult hearts.
    Ortmans S; Daval C; Aguilar M; Compagno P; Cadrin-Tourigny J; Dyrda K; Rivard L; Tadros R
    Expert Opin Pharmacother; 2019 Dec; 20(17):2101-2114. PubMed ID: 31566420
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological therapy in coronary heart disease: prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death.
    Kochs M; Eggeling T; Hombach V
    Eur Heart J; 1993 Sep; 14 Suppl E():107-19. PubMed ID: 8223747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Congestive heart failure and arrhythmia].
    Kasanuki H
    Nihon Rinsho; 1993 May; 51(5):1354-61. PubMed ID: 8101240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etiology and management of sustained ventricular tachycardia.
    Talwar KK; Naik N
    Am J Cardiovasc Drugs; 2001; 1(3):179-92. PubMed ID: 14728033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The benefits of the implantable cardioverter-defibrillator in comparisons with anti-arrhythmia agents in patients surviving malignant ventricular tachyarrhythmias: a subanalysis of the AVID study by varying degrees of left ventricular dysfunction. Antiarrhythmic versus Implantable Defibrillators].
    Occhetta E
    Ital Heart J Suppl; 2000 Apr; 1(4):577-8. PubMed ID: 10832149
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.